| Sr. No. | Generic Name | Composition | Packing | Category |
|---|---|---|---|---|
| 1 | Artesunate for Injection 120 mg | Each Combipack Contains: Sterile Artesunate…………………………………..120 mg This Pack Contains: Sodium Bi-Carbonate Injection BP……………5 % w/v Sodium Chloride Injection BP………………..…0.9 % w/v | Vial 5 ml Ampoule 10 ml Ampoule | Antimalerial |
| 2 | Artesunate for Injection 60 mg | Each Combipack Contains: Sterile Artesunate……………………………………60 mg This Pack Contains: Sodium Bi-Carbonate Injection BP……………5 % w/v Sodium Chloride Injection BP…………………..0.9 % w/v | Vial 5 ml Ampoule 10 ml Ampoule | Antimalerial |
| 3 | Artesunate for Injection 30 mg | Each vial Contains: Sterile Artesunate………………………….……….30 mg | Vial | Antimalerial |
| 4 | Azithromycin for Injection USP 500 mg | Each Vail Contains: Sterile Azithromycin dihydrate USP equivalent to anhydrous Azithromycin……500 mg (As lyophilized powder) | Vial | Antibacterial |
| 5 | Urokinase for Injection 5000 IU | Each Vial Contains: Urokinase BP…………………………………..………5000 IU Excipients………………………………………………..q.s. | Vial | Thrombolytic |
| 6 | Urokinase for Injection 25000 IU | Each Vial Contains: Urokinase BP……………………………………..…. 25000 IU Excipients……………………………………………..…q.s. | Vial | Thrombolytic |
| 7 | Urokinase for Injection 250000 IU | Each Vial Contains: Urokinase BP…………………………………….….…250000 IU Excipients…………………………………………….…q.s. | Vial | Thrombolytic |
| 8 | Urokinase for Injection 100000 IU | Each Vial Contains: Urokinase BP……………………………………..….100000 IU Excipients………………………………………………q.s. | Vial | Thrombolytic |
| 9 | Aztreonam for Injection USP 1000 mg | Each Vial Contains: Sterile Azteonam equivalent to Aztreonam anhydrous……….1000 mg (A sterile mixture of Aztreonam & L-Arginine) | Vial | Antibacterial |
| 10 | Aztreonam for Injection USP 2000 mg | Each Vial Contains: Sterile Azetreonam USP equivalent to Aztreonam anhydrous………2000 mg (A sterile mixture of Aztreonam & L-Arginine) | Vial | Antibacterial |
| 11 | Caspofungin Acetate 50 mg w/v | Each Vial Contains: Sterile Caspofungin Acetate equivalent to Caspofungin………………….…50 mg (As lyophilized powder) | Vial | Treatment of candidemia |
| 12 | Caspofungin Acetate for Injection 70 mg | Each Vial Contains: Sterile Caspofungin Acetate equivalent to Caspofungin……………………70 mg (As lyophilized powder) | Vial | Treatment of candidemia |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 13 | Esomeprazole for Injection 40 mg | Each Vial Contains: Sterile Esomeprazole Sodium Equivalent to Esomeprazole …………………40 mg (As Lyophilized powder) | Vial | GERD |
| 14 | Omeprazole Sodium for injection 40 mg | Each Vial Contains: Sterile Omeprazole Sodium BP Equivalent to Omeprazole……………….….…40 mg (As Lyophilized powder) | Vial | GERD |
| 15 | Pantoprazole for Injection BP 40 mg | Each Vial Contains: Sterile Pantaprazole Sodium BP Equivalent to Pantaprazole …………….……40 mg (As Lyophilized powder) | Vial | GERD |
| 16 | Cefazolin Sodium for Injection BP 500 mg | Each Vial Contains: Sterile Cefazolin Sodium BP equivalent to Cefazolin………………………...500 mg | Vial | Antibacterial |
| 17 | Cefazolin Sodium for Injection BP 1000 mg | Each Vial Contains: Sterile Cefazolin Sodium BP equivalent to Cefazolin…………………….….1000 mg | Vial | Antibacterial |
| 18 | Cefepime for Injection USP 500 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous……..500 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) | Vial | Antibacterial |
| 19 | Cefepime for Injection USP 1000 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous…….1000 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) | Vial | Antibacterial |
| 20 | Cefepime for Injection USP 2000 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous…….2000 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) | Vial | Antibacterial |
| 21 | Cefepime & Sulbactam for Injection 750 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP Equivalent to cefepime anhydrous………500 mg (A sterile mixture of cefepime Hydrochloride & L-Arginine) Sulbactam Sodium USP equivalent to Sulbactam…………………….250 mg | Vial | Antibacterial |
| 22 | Cefepime & Sulbactam for Injection 1.5 gm | Each Vial Contains: Sterile Cefepime Hydrochloride USP Equivalent to cefepime anhydrous…….1000 mg (A sterile mixture of cefepime Hydrochloride & L-Arginine) Sulbactam Sodium USP equivalent to Sulbactam…………………..500 mg | Vial | Antibacterial |
| 23 | Cefepime & Sulbactam for Injection 3.0 gm | Each Vial Contains: Sterile Cefepime Hydrochloride USP Equivalent to cefepime anhydrous…….2000 mg (A sterile mixture of cefepime Hydrochloride & L-Arginine) Sulbactam Sodium USP equivalent to Sulbactam…………………...1000 mg | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 24 | Cefepime & Tazobactam for Injection 2.25 gm | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous………2000 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) Sterile Tazobactum Sodium Equivalent to Tazobactum…………………..250 mg | Vial | Antibacterial |
| 25 | Cefepime & Tazobactam for Injection 281.25 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous………250 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) Sterile Tazobactum Sodium Equivalent to Tazobactum……………………31.25 mg | Vial | Antibacterial |
| 26 | Cefepime & Tazobactam for Injection 562.5 mg | Each Vial Contains: Sterile Cefepime Hydrochloride USP equivalent to Cefepime anhydrous………500 mg (A sterile mixture of Cefepime Hydrochloride& L-Arginine) Sterile Tazobactum Sodium Equivalent to Tazobactum……………………62.5 mg | Vial | Antibacterial |
| 27 | Cefoperazone Injection USP 500 mg | Each Vial Contains: Sterile Cefoperazone Sodium USP Equivalent TO Cefoperazone anhydrous…500 mg | Vial | Antibacterial |
| 28 | Cefoperazone for Injection USP 1.0 gm | Each Vial Contains: Sterile Cefoperazone Sodium USP Equivalent TO Cefoperazone anhydrous…1000 mg | Vial | Antibacterial |
| 29 | Cefoperazone & Sulbactam for Injection 500 mg | Each Vial Contains: Sterile Cefoperazone Sodium USP equivalent to Cefoperazone anhydrous ……250 mg Sterile Sulbactum Sodium USP Equivalent to Sulbactam…………………………..250 mg | Vial | Antibacterial |
| 30 | Cefoperazone & Sulbactam for Injection 750 mg | Each Vial Contains: Sterile Cefoperazone Sodium USP equivalent to Cefoperazone anhydrous ..…500 mg Sterile Sulbactum Sodium USP Equivalent to Sulbactam…………………………..250 mg | Vial | Antibacterial |
| 31 | Cefoperazone & Sulbactam for Injection 1.0 gm | Each Vial Contains: Sterile Cefoperazone Sodium USP equivalent to Cefoperazone anhydrous …..500 mg Sterile Sulbactum Sodium USP Equivalent to Sulbactam………………………….500 mg | Vial | Antibacterial |
| 32 | Cefoperazone & Sulbactam for Injection 1.5 gm | Each Vial Contains: Sterile Cefoperazone Sodium USP equivalent to Cefoperazone anhydrous .…1000 mg Sterile Sulbactum Sodium USP Equivalent to Sulbactam………………………..…500 mg | Vial | Antibacterial |
| 33 | Cefoperazone & Sulbactam for Injection 2.0 gm | Each Vial Contains: Sterile Cefoperazone Sodium USP equivalent to Cefoperazone anhydr…………1000 mg Sterile Sulbactum Sodium USP Equivalent to Sulbactam………………………….1000 mg | Vial | Antibacterial |
| 34 | Cefotaxime for Injection USP 500 mg | Each Vial Contains: Sterile Cefotaxime Sodium USP equivalent to Cefotaxime……………………….500 mg | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 35 | Cefotaxime for Injection USP 1000 mg | Each Vial Contains: Sterile Cefotaxime USP Equivalent to Cefotaxime………………………….1000 mg | Vial | Antibacterial |
| 36 | Cefotaxime Sodium Injection USP 2000 mg | Each Vial Contains: Sterile Cefotaxime USP Equivalent to Cefotaxime………………………….2000 mg | Vial | Antibacterial |
| 37 | Cefotaxime & Sulbactam for Injection 375 mg | Each Vail Contains: Sterile Cefotaxime USP Equivalent to Cefotaxime………………………….250 mg Sterile Sulbactam Sodium USP equivalent to sulbactam ……………………….….125 mg. | Vial | Antibacterial |
| 38 | Cefotaxime & Sulbactam for Injection 750 mg | Each Vail Contains: Sterile Cefotaxime USP Equivalent to Cefotaxime…………………...…….500 mg Sterile Sulbactam Sodium USP equivalent to sulbactam ………………………..…250 mg. | Vial | Antibacterial |
| 39 | Cefotaxime & Sulbactam for Injection 1.5 gm | Each Vail Contains: Sterile Cefotaxime USP Equivalent to Cefotaxime………………………...1000 mg Sterile Sulbactam Sodium USP equivalent to sulbactam …………………….……500 mg. | Vial | Antibacterial |
| 40 | Cefpirome for Injection 250 mg | Each Vial Contains: Sterile Cefpirome Sulphate equivalent to Cefprome…………………….….. 250 mg | Vial | Antibacterial |
| 41 | Cefpirome for Injection 500 mg | Each Vial Contains: Sterile Cefpirome Sulphate equivalent to Cefprome…………………………..500 mg | Vial | Antibacterial |
| 42 | Cefpirome for Injection 1 gm | Each Vial Contains: Sterile Cefpirome Sulphate equivalent to Cefprome…………………………..1000 mg | Vial | Antibacterial |
| 43 | Cefpirome & Sulbactam for Injection 750 mg | Each Vial Contains: Sterile Cefpirome Sulphate equivalent to Cefpirome…………………….……500 mg Sterile Sulbactum Sodium USP equivalent to Sulbactam…………………….……250 mg | Vial | Antibacterial |
| 44 | Ceftazidime for Injection USP 125 mg | Each Vial Contains: Ceftazidime Pentahydrate USP equivalent to Ceftazidime anhydrous………125 mg (A Sterile mixture of Ceftazidime Pentahydrate & Sodium Carbonate) | Vial | Antibacterial |
| 45 | Ceftazidime for Injection USP 250 mg | Each Vial Contains: Ceftazidine Pentahydrate USP equivalent to Ceftazidine anhydrous ……….250 mg (A mixture of Ceftazidine Pentahydrate & Sodium Carbonate) | Vial | Antibacterial |
| 46 | Ceftazidime for Injection USP 500 mg | Each Vial Contains: Ceftazidine Pentahydrate USP equivalent to Ceftazidine anhydrous ………500 mg (A mixture of Ceftazidine Pentahydrate & Sodium Carbonate) | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 47 | Ceftazidime for Injection USP 1000 mg | Each Vial Contains: Ceftazidine Pentahydrate USP equivalent to Ceftazidine anhydrous ………1000 mg (A mixture of Ceftazidine Pentahydrate & Sodium Carbonate) | Vial | Antibacterial |
| 48 | Ceftazidime for Injection USP 2000 mg | Each Vial Contains: Ceftazidine Pentahydrate USP equivalent to Ceftazidine anhydrous ………2000 mg (A mixture of Ceftazidine Pentahydrate & Sodium Carbonate) | Vial | Antibacterial |
| 49 | Ceftazidime & Sulbactam for Injection 750 mg | Each Vial Contain: Ceftazidime Pentahydrate USP Eq. to Ceftazidime anhydrous……………………500 mg (A Sterile mixture of Ceftazidime Pentahydrate & Sodium Carbonate) Sulbactam Sodium USP equivalent to Sulbactam……………………………250 mg | Vial | Antibacterial |
| 50 | Ceftazidime & Sulbactam for Injection 1.5 mg | Each Vial Contain: Ceftazidime Pentahydrate USP Eq. to Ceftazidime anhydrous………………….1000 mg (A Sterile mixture of Ceftazidime Pentahydrate & Sodium Carbonate) Sulbactam Sodium USP equivalent to Sulbactam………………………….500 mg | Vial | Antibacterial |
| 51 | Ceftriaxone Injection USP 125 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous …….125 mg | Vial | Antibacterial |
| 52 | Ceftriaxone Injection USP 250 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous ………250 mg | Vial | Antibacterial |
| 53 | Ceftriaxone Injection USP 500 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous ………500 mg | Vial | Antibacterial |
| 54 | Ceftriaxone Injection USP 1000 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous ………1000 mg | Vial | Antibacterial |
| 55 | Ceftriaxone & Sulbactam for Injection 1.5 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous………1000 mg Sterile Sulbactam Sodium USP equivalent to Sulbactam………………………….500 mg | Vial | Antibacterial |
| 56 | Ceftriaxone & Sulbactam for Injection 3000 mg | Each Vial Contains: Sterile Ceftriaxone Sodium USP equivalent to Ceftriaxone anhydrous……….2000 mg Sterile Sulbactam Sodium USP equivalent to Sulbactam………………………….1000 mg | Vial | Antibacterial |
| 57 | Cefuroxime for Injection USP 250 mg | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium……………..250 mg | Vial | Antibacterial |
| 58 | Cefuroxime for Injection USP 500 mg | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium………...…..500 mg | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 59 | Cefuroxime for Injection USP 750 mg | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium……………..750 mg | Vial | Antibacterial |
| 60 | Cefuroxime for Injection USP 1500 mg | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium……………..1500 mg | Vial | Antibacterial |
| 61 | Cefuroxime & Sulbactam for Injection 1125 mg | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium……….….…750 mg Sulbactam Sodium USP equivalent to sulbactam………………………….…375 mg | Vial | Antibacterial |
| 62 | Cefuroxime & Sulbactam for Injection 2.25 gm | Each Vial Contains: Sterile Cefuroxime Sodium USP equivalent to Cefuroxime Sodium……….……..1500 mg Sulbactam Sodium USP equivalent to sulbactam……………………….……750 mg | Vial | Antibacterial |
| 63 | Cerebroprotein Hydrolysate for Injection 30 mg | Each Vial Contains: Cerebroprotein Hydrolysate 1050 mg (approx) equivalent to Nitrogen ………………………….….30 mg (As Lyophilized powder) | Vial | Alzheimer's disease |
| 64 | Cerebroprotein Hydrolysate for Injection 60 mg | Each Vial Contains: Cerebroprotein Hydrolysate 2100 mg (approx) equivalent to Nitrogen ……………………………….60 mg (As Lyophilized powder) | Vial | Alzheimer's disease |
| 65 | Clarithromycin for Infusion BP 500 mg | Each Vial Contains: Sterile Clarithromycin BP……………………………..500 mg (As Lyophilized powder) | Vial | Antibacterial |
| 66 | Colistimethate Sodium for Injection BP 1 million IU | Each Vial Contains: Colistimethate sodium BP…………………1 Million IU | Vial | Antibacterial |
| 67 | Micafungin Sodium for injection 10 mg | Each Vial Contains: Sterile Micafungin Sodium Equivalent to Micafungin…………………….10 mg (As Lyophilized powder) | Vial | Antifungal |
| 68 | Micafungin Sodium for injection 50 mg | Each Vial Contains: Sterile Micafungin Sodium Equivalent to Micafungin…………….………50 mg (As Lyophilized powder) | Vial | Antifungal |
| 69 | Micafungin Sodium for injection 100 mg | Each Vial Contains: Sterile Micafungin Sodium Equivalent to Micafungin…………………..100 mg (As Lyophilized powder) | Vial | Antifungal |
| 70 | Minocycline for Injection USP 100 mg | Each Vial Contains: Sterile Minocycline Hydrochloride USP equivalent to Minocycline………………....100 mg (As lyophilized powder) | Vial | Treat Infection |
| 71 | Colistimethate Sodium for Injection BP 2million IU | Each Vial Contains: Colistimethate sodium BP………………….2 Million IU | Vial | Antibacterial |
| 72 | Colistimethate Sodium for Injection BP 4.5 million IU | Each Vial Contains: Colistimethate sodium BP……………………4.5 Million IU | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 73 | Colistimethate Sodium for Injection BP 5 million IU | Each Vial Contains: Colistimethate sodium BP…………………..5 Million IU | Vial | Antibacterial |
| 74 | Doripenem for Injection 250 mg | Each Vial Contains: Sterile Doripenem Monohydrate Equivalent to Doripenem ………………………250 mg | Vial | Antibacterial |
| 75 | Doripenem for Injection 500 mg | Each Vial Contains: Sterile Doripenem Monohydrate Equivalent to Doripenem ………………………500 mg | Vial | Antibacterial |
| 76 | Doxycycline for Injection USP 100 mg | Each Vial Contains: Sterile Doxycycline Hyclate USP equivalent to Doxycycline………………………100 mg | Vial | Antibacterial |
| 77 | Doxycycline for Injection USP 200 mg | Each Vial Contains: Sterile Doxycycline Hyclate USP equivalent to Doxycycline………………………200 mg | Vial | Antibacterial |
| 78 | Ertapenem For Injection 1000 mg | Each Vial Contains: Sterile Ertapenem Sodium Equivalent to Ertapenem Anhydrous ……1000 mg (As Lyophilized powder) | Vial | Antibacterial |
| 79 | Fosfomycin Sodium for Injection | Each Vial Contains: Sterile Fosfomycin Sodium BP equivalent to anhydrous Fosfomycin………4.0 gm (As lyophilized Powder) | Vial | Antibacterial |
| 80 | Ganciclovir Injection USP 500 mg | Each Vial Contains: Sterile Ganciclovir USP……………………………500 mg (As lyophilized powder) | Vial | Antiviral |
| 81 | Glutathione for Injection 600 mg | Each Vial Contains: Sterile Glutathione BP……………………………600 mg Excipients………………………………………………q.s. (As Lyophilized) | Vial | Skin brightening |
| 82 | Glutathione for Injection 1200 mg | Each Vial Contains: Sterile Glutathione BP ……………………………1200 mg Excipient……………………………………………..…q.s. (As Lyophilized powder) | Vial | Skin brightening |
| 83 | Hydrocortisone Sodium Succinate for Injection USP 100 mg | Each Vial Contains: Sterile Hydrocortisone Sodium Succinate USP equivalent to Hydrocortisone ………………100 mg | Vial | Anti-inflammatory adrenocortical steroid. |
| 84 | Methylprednisolone Sodium Succinate for Injection USP 40 mg | Each Vial Contains: Sterile Methylprednisollone Sodium Succinate USP Equivalent to Methylprednisolone ………40 mg | Vial | Synthetic Glucocorticoseteroids |
| 85 | Methylprednisolone Sodium Succinate for Injection USP 125 mg | Each Vail Contains: Sterile Methylprednisolone Sodium Succinate USP equivalent to Methylprednisone………….125 mg This Pack Contains: Sterile Water for injection USP………….10 ml | Vial | Synthetic Glucocorticoseteroids |
| 86 | Methylprednisolone Sodium Succinate for Injection USP 500 mg | Each Vial Contains: Sterile Methylprednisollone Sodium Succinate USP Equivalent to Methylprednisolone ………500 mg | Vial | Synthetic Glucocorticoseteroids |
| 87 | Methylprednisolone Sodium Succinate for Injection USP 1000 mg | Each Vial Contains: Sterile Methylprednisollone Sodium Succinate USP Equivalent to Methylprednisolone ……...500 mg | Vial | Synthetic Glucocorticoseteroids |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 88 | Hydrocortisone Sodium Succinate for Injection USP 200 mg | Each Vial Contains: Sterile Hydrocortisone Sodium Succinate USP equivalent to Hydrocortisone ……………200 mg | Vial | Anti-inflammatory adrenocortical steroid. |
| 89 | Hydrocortisone Sodium Succinate for Injection USP 500 mg | Each Vial Contains: Sterile Hydrocortisone Sodium Succinate USP equivalent to Hydrocortisone …………...500 mg | Vial | Anti-inflammatory adrenocortical steroid. |
| 90 | Imipenem & Cilastatin for Injection USP | Each Vial Contains: Sterile Imipenem USP Equivalent to anhydrous Imipenem……..25 mg Sterile Cilastine Sodium USP equivalent to Cilastine …………………………25 mg | Vial | Antibacterial |
| 91 | Imipenem & Cilastatin for Injection USP | Each Vial Contains: Sterile Imipenem USP Equivalent to anhydrous Imipenem………125 mg Sterile Cilastine Sodium USP equivalent to Cilastine ………………………….125 mg | Vial | Antibacterial |
| 92 | Imipenem & Cilastatin for Injection USP | Each Vial Contains: Sterile Imipenem USP Equivalent to anhydrous Imipenem………250 mg Sterile Cilastine Sodium USP equivalent to Cilastine ………………………….250 mg | Vial | Antibacterial |
| 93 | Imipenem & Cilastatin for Injection USP | Each Vial Contains: Sterile Imipenem USP Equivalent to anhydrous Imipenem………500 mg Sterile Cilastine Sodium USP equivalent to Cilastine …………………………500 mg | Vial | Antibacterial |
| 94 | Lansoprazole for Injection | Each Vial Contains: Sterile Lansoprazole Sodium Eqi. To Lansoprazole………………………………30 mg (As lyophilized powder) | Vial | GERD |
| 95 | Meropenem for Injection USP 125 mg | Each Vial Contains: Sterile Meropenem USP Equivalent to anhydrous Meropenem ……125 mg Sodium (as Sodium Carbonate)……………….11.275 mg | Vial | Antibacterial |
| 96 | Meropenem for Injection USP 250 mg | Each Vial Contains: Sterile Meropenem USP Equivalent to anhydrous Meropenem ……250 mg Sodium (as Sodium Carbonate)……………….22.55 mg | Vial | Antibacterial |
| 97 | Meropenem For Injection USP 500 mg | Each Vial Contains: Sterile Meropenem USP Equivalent to anhydrous Meropenem ……500 mg Sodium (as Sodium Carbonate)……………….45.1 mg | Vial | Antibacterial |
| 98 | Meropenem For Injection USP 1000 mg | Each Vial Contains: Sterile Meropenem USP Equivalent to anhydrous Meropenem ….1000 mg Sodium (as Sodium Carbonate)……………...90.2 mg | Vial | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 99 | Polymyxin B for Injection USP 500,000 Units | Each Vial Contains: Polymyxin B Sulfate USP equivalent to polymyxin B……………500,000 Units (as Lyophilized Powder) | Vial | Antibacterial |
| 100 | Polymyxin B for Injection USP 750,000 Units | Each Vial Contains: Polymyxin B Sulfate USP equivalent to polymyxin B……………750,000 Units (as Lyophilized Powder) | Vial | Antibacterial |
| 101 | Rabeprazole Injection USP 20 mg | Each Vial Contains: Sterile Rabeprazole Sodium USP…20 mg (As Lyophilized powder) | Vial | GERD |
| 102 | Streptokinase for Injection BP 250,000 Units | Each Vial Contains: Streptokinase BP…………………………2,50,000 Units Excipients……………………………………q.s. | Vial | treat blood clots |
| 103 | Streptokinase for Injection BP 7,50,000 Units | Each Vial Contains: Streptokinase BP…………………………7,50,000 Units Excipients……………………………………q.s. | Vial | treat blood clots |
| 104 | Teicoplanin for Injection 100 mg | Each Vial Contains: Sterile Teicoplanin BP…………………100 mg (As lyophilized powder) | Vial | Anti Bacterial |
| 105 | Teicoplanin Injection 200 mg | Each Vial Contains: Sterile Teicoplanin BP…………………200 mg (As Lyophilized Powder) | Vial | Anti Bacterial |
| 106 | Teicoplanin for Injection 400 mg | Each Vial Contains: Sterile Teicoplanin BP…………………400 mg (As Lyophilized Powder) | Vial | Anti Bacterial |
| 107 | Tigecycline for Injection USP 50 mg | Each Vial Contains: Sterile Tigicycline USP…………………50 mg (As lyophilized powder) | Vial | Treat Infection |
| 108 | Tigecycline for Injection 100 mg | Each Vial Contains: Sterile Tigecycline USP…………………100 mg (As Lyophilized Powder) | Vial | Antibacterial |
| 109 | Ulinastatin for Injection 50000 I.U. | Each Vial Contains: Ulinastatin JP…………………………….…50000 I.U. excipients…………………………………….q.s. | Vial | Protease Inhibitor |
| 110 | Ulinastatin for Injection 100000 I.U. | Each Vial Contains: Ulinastatin BP………………………………100000 I.U. excipients……………………………………..q.s. | Vial | Protease Inhibitor |
| 111 | Urokinase for Injection 500000 IU | Each Vial Contains: Urokinase BP……………………………..…500000 IU Excipients………………………………..….…q.s. | Vial | Trombolytic |
| 112 | Vancomycin Hydrochloride for Injection USP 500 mg | Each Vial Contains: Sterile Voncomycin Hydrochloride USP Eqivalent to Vancomycin………………500mg | Vial | Treat Infection |
| 113 | Anidulafungin for injection 50 mg | Each ml Contains: Sterile Anidulafungin………………………….50 mg (As lyophilized Powder) Excipients…………………………………….…….q.s. | 20 ml Vial | Antifungal |
| 114 | Anidulafungin for Injection 100 mg | Each Vial Contains: Sterile Anidulafungin…………………………100 mg (As lyophilized powder) Excipients………………………………………....q.s. | 20 ml Vial | Antifungal |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 115 | Vancomycin Hydrochloride for Injection USP 1000 mg | Each Vial Contains: Sterile Voncomycin Hydrochloride USP Eqivalent to Vancomycin………………..….1000mg | Vial | Treat Infection |
| 116 | Voriconazole for Injection 200 mg | Each Vial Contains: Sterile Voriconazole USP……………………200 mg (As lyophilized powder) | Vial | Antigungal |
| 117 | Acyclovir For injection USP 500 mg | Each Vial Contains: Sterile Acyclovir Sodium USP equivalent to Acyclovir………………………500 mg | Vial | Antiviral |
| 118 | Vecuronium Bromide for injection BP | Each Vial Contains: Vecuronium Bromide BP…………………….10 mg Excipients……………………………………………q.s. | Vial | Neuromuscyular bloking agaent |
| 119 | Liposomal Amphotericin B Injection | Each Vial Contains: Amphotericin B BP (Intercalated into Liposomal Membrane)50mg Excipients……………………………………………q.s. | Vial | Antifungal |
| Sr. No. | Generic Name | Composition | Packing | Category |
| LIQUID INJECTION | LIQUID INJECTION | LIQUID INJECTION | LIQUID INJECTION | LIQUID INJECTION |
| 120 | Gadopentetate Dimeglumine Injection USP | Each ml Contains: Gadopentetate Dimeglumine……………….………………469.01 mg Water for injection USP……………….q.s. | 10ml/20ml Vial | Diagnose abnormalities during a MRI. |
| 121 | Iohexol Injection USP 350mg | Each ml Contains: Iohexol USP………………………………...0.755 gm Equivalent to Iodine…………………….350.0 mg Excipients…………………………………….q.s. | 50ml/100ml | Diagnose in the brain, back, heart, head, blood vessels, stomach, joints, pancreas the body. |
| 122 | Iohexol Injection USP 300mg | Each ml Contains: Iohexol USP………………………………...0.647 gm Equivalent to Iodine………………..….300.0 mg Excipients…………………………..……….q.s. | 50ml/100ml | Diagnose in the brain, back, heart, head, blood vessels, stomach, joints, pancreas the body. |
| 123 | Acetyl Cysteine Solution USP | Each ml Contains: Acetylcystein USP……………………….100 mg Water For injection USP……………...q.s. | 2/3/5 ml Ampoule | Used for respiratory disease |
| 124 | Acetylcysteine Solution USP | Each ml Contains: Acetylcystein USP………………….……200 mg Water For injection USP……….…….q.s. | 2 ml/5 ml/10 ml Ampoule | Used for respiratory disease |
| 125 | Amphotericin B Emulsion | Each ml Contains: Amphotericin B USP……………….….5 mg In a vehicle containing Soyabean Oil USP, Glycerin USP, Egg Lecithin, Sodium Hydroxide USP and water for injection USP | 10 ml/20 ml Vial | Antifungal |
| 126 | Aprotinin Injection USP 10000 KIU | Each ml Contains: Aprotinin USP……………………………1000 KIU Sodium Chloride USP………………….9 mg Water for injection USP……….…….q.s. | 10 ml Vial | Serine Protease inhibitor |
| 127 | Artemether Injection | Each ml Contains : Artemether BP.…………………..……..40 mg Oily Base………………………………….…q.s. | 1 ml Ampoule | Antimalerial |
| 128 | Artemether Injection 80 mg | Each ml Contains: Artemether………………………………..80 mg Oily Base…………………………………….q.s. | 1 ml Ampoule | Antimalerial |
| 129 | Ascorbic Acid Injection BP | Each ml Contains: Ascorbic Acid BP…………………………100 mg Water for Injection………………….….q.s. | 5 ml Vial/Ampoule | Treat Vitamin C deficiency |
| 130 | Ascorbic Acid Injection BP | Each ml contains: Ascorbic Acid BP…………………………200 MG Water for injection BP………….…….q.s. | 50 ml | Treat vitamin C Deficiency |
| 131 | Atracurium Besylate Injection USP 50 mg | Each ml Contains : Atracurium Besylate USP…………...10 mg Benzyl Alcohol USP…………………..…0.9 % v/v (As Preservative) Water for Injection USP……………...q.s. | 2.5 ml Ampoule | Muscle Relaxants |
| 132 | Atracurium Besylate Injection USP 50 mg | Each ml Contains : Atracurium Besylate USP…………….10 mg Water for Injection USP……………....q.s. | 5 ml Ampoule | Muscle Relaxants |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 133 | Atropine Sulphate Injection USP | Each ml Contains: Atropine Sulfate Monohydrate USP….1.0 mg Water for injection USP…………………….q.s. | 1 ml Ampoule | Anticholinergic |
| 134 | Cholecalciferol Injection BP 300000 IU | Each ml Contains: Cholecalciferol BP………………….300000 IU Ethyl Oleate BP………………………q.s. | 1 ml Ampoule | Treat Vitamin D deficiency |
| 135 | Cholecalciferol Injection BP 600000 IU | Each ml Contains: Cholecalciferol BP……………….…600000 IU Ethyl Oleate BP………………………q.s. | 1 ml Ampoule | Treat Vitamin D deficiency |
| 136 | Cisatracurium Besylate Injection USP | Each ml contains: Cisatracurium Besylate USP…….2 mg Water for Inject ion USP……...…q.s. | 5 ml/10 ml Vial | Muscle relaxants |
| 137 | Citicoline Injection 500 mg | Each ml Contains : Citicoline Sodium Eq. to Citicoline…………….………..125 mg Water for Injection USP………..…q.s. | 2ml Ampoule | Treat alzheimer's Disease |
| 138 | Citicoline Injection 1000 mg | Each ml Contains : Citicoline Sodium Eq. to Citicoline………………..…...250 mg Water for Injection USP….………q.s. | 4.0 ml Ampoule | Treat alzheimer's Disease |
| 139 | Clindamycin Injection BP 300 mg | Each ml Contains : Clindamycin Phosphate BP Eq. to Clindamycin………………….150 mg Benzyl Alcohol BP……….….………0.9% v/v Water for Injection BP….…..……q.s. | 2 ml Ampoule | Lincomycin Antibiotics |
| 140 | Clindamycin Injection BP 600 mg | Each ml Contains : Clindamycin Phosphate BP Eq. to Clindamycin………………….150 mg Benzyl Alcohol BP……….…….……0.9% v/v Water for Injection BP……..……q.s. | 4.0 ml Ampoule | Lincomycin Antibiotics |
| 141 | Cyanocobalamin Injection USP | Each ml contains: Cyanocobalamin USP……………..1000 mcg Benzyl Alcohol USP………….…….2.0 % v/v (As preservative) Water for injection USP………….q.s. | 1 ml Ampoule | Prevent Vitamin B12 Deficiency |
| 142 | Cyanocobalamin, Thiamine HCl, Pyridoxine HCl, Niacinamide, & D-Panthenol Injection | Each 3 ml Contains: Cyanocobalamin BP………………..1000 mcg Thiamine HCL BP…………………….100 mg Pyridoxine HCL BP…………………..100 mg Niacinamide BP……………………….100 mg D-Panthol BP……………………………50 mg Benyl Alcohol BP…………….………..2.0 % v/v (As preservative) Water for injection BP................q.s. | 3 ml Ampoule | Prevent Vitamin B12 Deficiency |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 143 | Diclofenac Sodium Injection 75mg/3ml | Each ml Contains : Diclofenac Sodium BP……………….25 mg Benzyl Alcohol BP…………………….4% v/v (As Preservative) Water for Injection BP………………q.s. | 3 ml Ampoule | NSAIDs |
| 144 | Sodium Chloride Injection BP 0.9 % w/v | Composition: Sodium Chloride BP…………………..0.9 % w/v Water for injection USP………………q.s. | 5/10 ml | Treat Hyponatremia Low salt syndrome |
| 145 | Dopamine Hydrochloride Injection USP | Each ml Contains: Dopamine Hydrochloride USP………40 mg Water for injection USP……………….q.s. | 5 ml Ampoule | Treat hemodynamic imbalances |
| 146 | Drotaverine HCl Injection 40 mg | Each 2 ml Contains: Drotaverine Hydrochloride ………….40.0 mg Water for injection USP…………….….q.s. | 2 ml Ampoule | Antispasmodic |
| 147 | Enoxaparin Sodium Injection BP 40 mg (Low Molecular Weight Heparin) | Each 0.4 ml Contains: Enoxaparin Sodium BP…………………40 mg (Porcine derived) Water for injection BP…………………q.s. to 0.4 ml | 0.4 ml PFS | Anticoagulant |
| 148 | Enoxaparin Sodium Injection BP 60 mg (Low Molecular Weight Heparin) | Each 0.6 ml Contains: Enoxaparin Sodium BP…………………60 mg (Porcine derived) Water for injection BP…………………q.s. to 0.6 ml | 0.6 ml PFS | Anticoagulant |
| 149 | Enoxaparin Sodium Injection BP 80 mg (Low Molecular Weight Heparin) | Each 0.8 ml Contains: Enoxaparin Sodium BP…………………80 mg (Porcine derived) Water for injection BP…………………q.s. to 0.8 ml | 0.8 ml PFS | Anticoagulant |
| 150 | Flupentixol Injection BP 20 mg | Each ml Contains: Flupentixol Decanoate BP……….…..20 mg Oily Base…………………….……………...q.s. | 1 ml Ampoule | Antipsychotics |
| 151 | Fluphenazine Decanoate Injection USP 25 mg | Each ml Contains: Fluphenazine Decanoate USP………25 mg Oily Base……………………………………….q.s. | 1 ml Ampoule | Antipsychotics |
| 152 | Furosemide Injection USP | Each ml contains: Furesomide USP…………………………..10 mg Water for injection USP…………….…q.s. | 2 ml Ampoule | Diuretic |
| 153 | Gentamicin Injection | Each ml Contains: Gentamicin Sulfate BP equivalent to Gentamicin……………40.0 mg Methyl Paraben (As preservative) BP1.8 MG Propyl Paraben (As Preservative) BP….0.2 mg Water for injection BP…………………….q.s. | 2 ml Ampoule | Antibacterial |
| 154 | Haloperidol Decanoate Injection | Each ml Contains: Haloperidol Decanote USP equivalent to Haloperidol…………….50mg Benzyl Alcohol……………………………..1.5 % v/v (As Preservative) Sesame Oil USP…………………………….q.s. | 1 ml Ampoule | Antipsychotics |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 155 | Haloperidol Injection BP | Each ml Contains: Haloperidol BP………………………..….2 mg Benzyl Alcohol BP………………….……2.0 % v/v Water for injection BP…………………q.s. | 1 ml | Antipsychotic |
| 156 | Haloperidol Decanoate Injection | Each ml Contains: Haloperidol Decanote USP equivalent to Haloperidol……………100mg Benzyl Alcohol………………..…………..1.5 % v/v (As Preservative) Sesame Oil USP………………………..….q.s. | 1 ml Ampoule | Antipsychotics |
| 157 | Heparin Injection BP 25000 IU/5 ml | Each ml Contains: Heparin Sodium BP……….…………….5000 IU (Derived from Bovine Mucosa) Benzyl Alcohol BP……………………...0.95% v/v (As Preservative) Water for Injection BP………………..q.s. | Vial | Anticoagulant |
| 158 | Heparin Injection BP 5000 IU/5 ml | Each 5 ml Contains: Heparin Sodium BP…………………...5000 IU (Derived from Bovine Mucosa) Benzyl Alcohol BP………………….….0.95% v/v (As Preservative) Water for Injection BP………………..q.s. | Vial | Anticoagulant |
| 159 | Hydralazine Hydrochloride Injection USP 20 mg | Each ml Contains: Hydralazine Hydrochloride USP….20 mg Water froinjection USP……….……..q.s. | 1 ml Ampoule | viscosupplementation agents |
| 160 | Hyoscine Butylbromide Injection BP 20 mg | Each ml Contains: Hyoscinc Butylbromide BP…………..20 mg Water for Injection BP………………..q.s. | 1 ml Ampoule | Antispasmodic |
| 161 | Iron Sucrose Injection BP 20 mg | Each ml Contains : Ferric Hydroxide in complex with Sucrose eq. to Elemental Iron…20 mg Water for Injection BP…………………….q.s. | 5 ml Ampoule | Treat iron deficiency |
| 162 | Ketorolac Tromethamine Injection USP | Each ml Contains : Ketorolac Tromethamine USP……….…30 mg water for injection USP……………………q.s. | 2 ml Ampoule | NSAID |
| 163 | Labetalol Injection | Each ml Contains: Labetamol Hydrochloride USP…………..5.0 mg water for injection USP………………………q.s. | 20 ml Ampoule | Treat Hypertension |
| 164 | Labetalol Injection | Each ml Contains: Labetamol Hydrochloride USP…………..10.0 mg water for injection USP .……………………q.s. | 20 ml Ampoule | Treat Hypertension |
| 165 | Levetiracetam Injection USP 500 mg | Each ml Contains: Levetiracetam USP…………………..……….100 mg Water for injection USP………………..…..q.s. | 5 ml Vial | Treat partial onset seizures |
| 166 | Levocarnitin Injection USP I000 mg | Each ml Contains: Levocanitine USP……………………………….200 mg Water for Injection USP……………………..q.s. | 5 ml Ampoule | Treat carnitine deficiency |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 167 | Lidocaine Injection BP 1 % w/v | Each ml Contains: Lidocaine Hydrochloride BP…………….1.0 % w/v Water for injection BP……………………..q.s. | 10 ml Vial | local anesthetic nerve blocking |
| 168 | Lignocaine Injection BP | Composition: Lignocaine Hydrochloride MonohydrateBP2.0% Water for Injection BP………………………q.s. | 50 ml Vial | Local anesthetic |
| 169 | Magnesium Sulphate Injection USP | Each ml Contains: Magnesium Sulphate Heptahydrate USP500 mg Water for injection USP……………………….q.s. | 10ml Ampoule | Hypomagnesemia |
| 170 | Mecobalamin Injection 1000 mcg | Each ml Contains: Mecobalamin JP………………………..1000 mcg Benzyl Alcohol USP…………………….2.0% v/v (As preservative) Water for Injection USP………………q.s. | 1 ml Ampoule | Treat megaloblastic |
| 171 | Methylprednisolone Acetate Injection USP 40 mg | Each Vial Contains: Methylprednisolone Acetate USP…40 mg Benzyl Alcohol USP……………..……….2 % v/v (As Preservative) Water for injection USP…………………q.s. | 1 ml Vial | Anti-inflammatory glucocorticoids |
| 172 | Methylprednisolone Acetate Injectable Suspension USP 80 mg | Each Vial Contains: Methylprednisolone Acetate USP……40 mg Benzyl Alcohol USP………………………….2 % v/v (As Preservative) Water for injection USP……………………q.s. | 2 ml Vial | Anti-inflammatory glucocorticoids |
| 173 | Neostigmine Methylsulphate Injection USP | Each ml Contains: Neostigmine Methylsulphate USP…….0.5 mg Water for injection BP………………………q.s. | 5 ml Ampoule | Cholinesterase Inhibitor |
| 174 | Nitroglycerine Injection USP | Each ml Contains: Diluted Nitroglycerin USP………………..5 mg Water for injection BP……………………..q.s. | 5 ml/10 ml Ampoule | CHF |
| 175 | Noradrenaline Injection BP | Each ml Contains: Noradrenaline Acid Tartrate BP equivalent to Noradrenaline……….…..1 mg Water for Injection BP………………...….q.s. | 1 ml Ampoule | Treat Hypotension |
| 176 | Octreotide Injection | Each ml Contains: Octreotide Acetate USP equivalent to Octreotide………………….50 mcg Water for injection USP………………..…..q.s. | 1 ml Ampoule | Treat Severe diarrhea |
| 177 | Octreotide Injection | Each ml Contains: Octreotide Acetate USP equivalent to Octreotide………….….….100 mcg Water for injection USP…………………..q.s. | 2 ml Ampoule | Treat Severe diarrhea |
| 178 | Ondansetron Injection USP | Each ml Contains: Ondansetron Hydrochoride USP Equivalent to Ondansetron……………2 mg Water for injection………………………..q.s. | 4 ml Ampoule | Serotonin 5-HT 3 receptor antagonists |
| 179 | Pancuronium Injection BP | Each 2 ml Contains: Pancuronium Bromide BP……………….4 mg Water for injection BP…………………….q.s. | 2 ml Ampoule | 5-HT 3 antagonist |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 180 | Piracetam Injection 3.0 gm | Each 15 ml Contains: Piracetam BP……………………………….….3.0 gm Water for Injection BP……………………..q.s. | 15 ml Ampoule | Treat alzheimer's Disease |
| 181 | Piroxicam Injection 40 mg | Each 2 ml Contains: Piroxicam USP…………………………………40 mg Benzyl Alcohol USP………………………….40 mg (as preservative) Ethanol USP…………………………………….12.6 % v/v | 2 ml Ampoule | NSAID |
| 182 | Potassium Chloride for Injection Concentrate USP | Each ml contains: Potassium Chloride USP…………………150 mg Water for injection USP………………….q.s. | 10 ml Ampoule | Treat potassium deficiency |
| 183 | Prednisolone Sodium Phosphate Injection USP | Each ml Contains: Prednisolone Sodium Phosphate USP equivalent to prednisolone Phosphate…5mg Water for Injection USP………………………q.s. | 10 ml Vial | Adrenocorticoid |
| 184 | Prednisolone Sodium Phosphate Injection USP | Each ml Contains: Prednisolone Sodium Phosphate USP equivalent to prednisolone Phosphate…20 mg Water for Injection USP…………………………q.s. | 2 ml Vial | Adrenocorticoid |
| 185 | Propofol Injectable Emulsion USP | Each ml Contains: Propofol USP…………………………………20 mg Water for Injection USP…………………q.s. | 10/20/50 ml Vial | General anaesthesia |
| 186 | Propofol Injectable Emulsion USP | Each ml Contains: Propofol USP………………………….……10 mg Water for Injection USP…………………q.s. | 10/20 /50 ml Vial | General anaesthesia |
| 187 | Ranitidine Injection USP 50 mg | Each ml Contains: Ranitidine Hydrochloride USP equivalent to Ranitidine……………..25 mg Phenol USP………………………….……..0.5 % w/v (As Preservative) Water for injection BP……………….q.s. | 1/2 ml Ampoule | GERD |
| 188 | Rocuronium Bromide Injection 100 mg/10ml | Each ml Contains: Rocuronium Bromide USP…………10 mg Water fro injection USP………………q.s. | 10 ml | Non polarizing neuromuscular agent |
| 189 | Sodium Bicarbonate Injection BP | Each Vial Contains: Sodium Bicarbonate USP……………5.0 % w/v Water for injection USP ……………..q.s | 10ml/20ml/ 50ml/100ml Vial | Antacids Minerals Electrolytes Urinary Ph modifiers |
| 190 | Sodium Bicarbonate Injection USP 8.4 % w/v | Each 100 ml Contains: Sodium Bicarbonate USP…………….8.4 gm Water for injection USP……………….q.s. | 10ml/20ml/ 50ml/100ml Vial | Antacids Minerals Electrolytes Urinary Ph modifiers |
| 191 | Succiuylcholine Chloride Injection USP (Suxamethonium Chloride InjectionUSP) | Each ml Contains : Succinylcholine Chloride USP………50 mg Water for Injection USP………………q.s. | 2 ml Ampoule | Muscle relaxants |
| 192 | Terlipressin Injection 1.0 mg | Each 10 ml Contains: Terlipressin Acetate Equivalent to Terlipressin……….….1 mg Water for injection USP………………q.s. | 10 ml | Vasopressin receptor agonists |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 193 | Thiocolchicoside Injection 4 mg | Each 2 ml Contains: Thiocolchicoside BP……………………4mg Water for injection BP…………………q.s. | 2 ml Ampoule | Muscle relaxants with anti- inflammatory & analgesic |
| 194 | Dexamethasone Sodium Phosphate Injection USP | Each ml Contains: Dexamethasone Sodium Phosphate USP Equivalent to Dexamethasone Phosphate..4mg Water for injection USP……………………q.s. | 2 ml | Anti-Inflammatory & Autoimmune conditions |
| 195 | Tobramycin for injection USP | Each ml Contains: Tobramycin Sulfate USP equivalent to Tobramycin…………….40 mg Phenol………………………………….……..0.5 % w/v As Preservative) Water for injection BP…………….……q.s. | 2 ml Vial | Antibacterial |
| 196 | Tranexamic Acid Injection BP 500 mg | Each ml Contains : Tranexamic Acid BP……………………100 mg Water for Injection BP……………….…q.s. | 5 ml Ampoule | Antifibrinolytic |
| 197 | Triamcinolone Acetonide Injection 40 mg | Each ml contains: Triamcinolone Acetonide BP…………40 mg Benzyl Alcohol BP…………………..…….0.9 % v/v (As Preservative) Water for injection BP…………….……q.s. | 1 ml Vial | Anti-Inflammatory |
| 198 | Vecuronium Bromide Injection BP | Each Vial Contains: Vecuronium Bromide BP………………10 mg Excipients…………………………………….q.s. | Vial | Neuromuscular bloking agent |
| 199 | Verapamil Injection BP | Each ml Contains: Verapamil Hydrochloride BP…………2.5 mg Water for injection BP…………………..q.s. | 2 ml Ampoule | Treat Hypertension Angina Heart rhythm |
| 200 | Vitamin C Injection USP and Methylcobalamin, Folic Acid & Niacinamide Injection | Each 1.5 ml Contains: Vitamin C USP……………………………...150 mg Water for injection USP…………………q.s. Each ml Contains: Methylcobalamin USP……………………2500 mcg Folic Acid USP………………………………..0.7 mg Niacinamide USP……………………………12 mg Benzyl Alcohol USP…………………………2 % v/v (As Preservative) Water for injection USP……………………q.s. | 2 ml combi pack | Treat nutritional deficiences |
| 201 | Zinc Chloride Injection USP | Each ml Contains: Zinc Chloride USP……………………………2.09 mg (equivalent to elemental Zinc)………..1.0 mg Sodium Chloride USP……………………...9.0 mg Water for injection USP…………………..q.s. | 10ml Ampoule | Maintain zinc serum levels |
| 202 | Zuclopenthixol Acetate Injection BP | Each ml Contains : Zuclopenthixol Acetate BP………………50 mg Oily base………………………………………...q.s. | 1 ml Ampoule | Antipsychotic |
| 203 | Zuclopenthixol Decanoate Injection BP | Each ml Contain: Zuclopenthixol Decanoate BP………....50.0 mg Oily Base………………………………………….q.s. | 1 ml Ampoule | Antipsychotic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| MDI | MDI | MDI | MDI | MDI |
| 204 | Beclometasone Dipropionate & Levosalbutamol Inhaler | Each Actuation Delivers: Beclometasone Dipropionate BP………………..50 mcg Levosalbutamol Sulphate BP equivalent to Levosalbutamol………………….…50 mcg Suspended in propellant HFA 134a………….…q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 205 | Zuclopenthixol Decanoate Injection BP | Each ml Contain: Zuclopenthixol Decanoate BP………….200.0 mg Oily Base………………………………………….q.s. | 1 ml Ampoule | Antipsychotic |
| 206 | Lidocaine Injection BP 2.0 % w/v | Each ml Contains: Lidocaine Hydrochloride BP…..…………21.3 Sodium Chloride BP………………………….6.0 mg Water for injection…………………………..q.s. | 20 ml | Local anesthetic |
| 207 | Beclometasone Dipropionate & Salbutamol Inhaler | Each Actuation Delivers: Beclometasone Dipropionate BP……………….50 mcg Salbutamol Sulphate BP equivalent to salbutamol……………………….….100 mcg Suspended in propellant HFA 134a………….…q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 208 | Beclomethasone Pressurised Inhalation BP 50 mcg | Each actuation delivers: Beclometasone Dipropionate BP………..……..50 mcg Suspended in Propellent HFA 134a…………….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 209 | Budesonide Pressurised Inhalation BP | Each Actuation Delivers: Budesonide BP…………………………………………100 mcg Suspended in propellant HFA 134a………..…q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 210 | Budesonide Pressurised Inhalation BP | Each Actuation Delivers: Budesonide BP…………………………………………200 mcg Suspended in propellant HFA 134a………..…q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 211 | Ciclesonide Pressurised Inhalation 80 mcg | Each Actuation Delivers: Ciclesonide BP……………………………………80 mcg Suspended in propellant HFA 134a…….q.s. | 120 MDI | COPD, Antiasthmatic |
| 212 | Ciclesonide Pressurised Inhalation 160 mcg | Each Actuation Delivers: Ciclesonide BP……………………………………160 mcg Suspended in propellant HFA 134a……..q.s. | 120 MDI | COPD, Antiasthmatic |
| 213 | Ciclesonide and Formoterol Fumarate Inhaler | Each Actuation Delivers: Ciclesonide BP……………………………………80 mcg Formoterol Fumarate Dihydrate BP equivalent to formeterol Fumarate…….4.5 mcg Suspended in propellant HFA 134a……..q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 214 | Fluticasone Propionate Inhalation BP | Each Actuation Delivers: Fluticasone Propionate BP………………….50 mcg Suspended in Propellant HFA 134a……..q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 215 | Fluticasone Propionate Inhalation BP | Each Actuation Delivers: Fluticasone Propionate BP……………….…125 mcg Suspended in Propellant HFA 134a……..q.s. | 60 MDI | COPD, Antiasthmatic |
| 216 | Fluticasone Propionate Inhalation BP | Each Actuation Delivers: Fluticasone Propionate BP…………………250 mcg Suspended in Propellant HFA 134a…….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 217 | Fluticasone Propionate & Formoterol Fumarate Inhaler | Each Actuation Delivers: Fluticasone Propionate BP…………………100 mcg Formeterol Fumarate Dihydrate BP equivalent to Formoterol Fumarate……6 mcg Suspended in propellant HFA 134a…….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 218 | Fluticasone Propionate & Formoterol Fumarate Inhaler | Each Actuation Delivers: Fluticasone Propionate BP………………….250 mcg Formoterol Fumarate Dihydrate BP equivalent to Formoterol Fumarate……6 mcg Suspended in propellant HFA 134a…….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 219 | Levosalbutamol Inhaler 50 mcg | Each Actuation Delivers: Levosalbutamol Sulphate equivalent to Levosalbutamol ………….50 mcg Suspended in propellant HFA 134a ……q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 220 | Levosalbutamol Inhaler 100 mcg | Each Actuation Delivers: Levosalbutamol Sulphate equivalent to Levosalbutamol ………….100 mcg Suspended in propellant HFA 134a..….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 221 | Mometasone Furoate & Formoterol Fumarate Inhaler | Each Actuation Delivers: Mometasone Furate BP……………………100 mcg Formoterol Fumarate Dihydrate BP equivalent to Formeterol Fumarate….6 mcg Suspended in Propellant HFA 134a…...q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 222 | Salbutamol Pressurised Inhalation, Suspension BP | Each Actuation Delivers: Salbutamol Sulphate BP equivalent to Salbutamol …………………100 mcg Suspended in propellant HFA 134a ……q.s. | 200 MDI | COPD, Antiasthmatic |
| 223 | Fluticasone and Salmeterol pressurised Inhalation suspension BP | Each Actuation Delivers: Fluticasone Propionate BP……………….50 mcg Salmeterol Xinofoate BP Equvalent to Salmeterol……………………25 mcg Suspended in propellant HFA 134a …..q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 224 | Fluticasone and Salmeterol pressurised Inhalation suspension BP | Each Actuation Delivers: Fluticasone Propionate BP………………250 mcg Salmeterol Xinofoate BP Equvalent to Salmeterol……………………25 mcg Suspended in propellant HFA 134a ……q.s. | 120 MDI | COPD, Antiasthmatic |
| 225 | Salmeterol Pressurised Inhalation, Suspension BP 25 mcg | Each actuation delivers: Salmeterol BP…………………………………..25 mcg (as Salmeterol Xinafoate) Suspended in Propellant HFA 134a……q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 226 | Tiotropium Bromide & Formoterol Fumarate Inhaler | Each Actuation Delivers: Tiotropium Bromide Monohydrate BP equivalent to Tiotropium ……………….9 mcg Formoterol Fumarate dihydrate BP equivalent to Formoterol Fumarate…12mcg Suspended in propellant HFA 134a ….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 227 | Tiotropium Bromide , Formoterol Fumarate & Ciclesonide Inhaler | Each Actuation Delivers: Tiotropium Bromide Monohydrate BP equivalent to Tiotropium ……………….9 mcg Formoterol Fumarate dihydrate BP equivalent to Formoterol Fumarate…6 mcg Ciclesonide BP………………….……..…....200 mcg Suspended in propellant HFA 134a ...q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 228 | Tiotropium Bromide Inhaler 9 mcg | Each Actuation Delivers: Tiotropium Bromide Monohydrate BP equivalent to Tiotropium ……………....9 mcg Suspended in propellant HFA 134a ….q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 229 | Beclomethasone Pressurised Inhalation BP 125 mcg | Each Actuation delivers: Beclometasone Dipropionate BP………125 mcg Suspended in Propellent HFA 134a……q.s. | 120/200 MDI | COPD, Antiasthmatic |
| 230 | Budesonide Pressurised Inhalation BP | Each Actuation Delivers: Budesonide BP…………………………………50 mcg Suspended in propellant HFA 134a……q.s. | 120/200 MDI | COPD, Antiasthmatic |
| NASAL SPRAY (METERED DOSE) & NASAL DROPS | NASAL SPRAY (METERED DOSE) & NASAL DROPS | NASAL SPRAY (METERED DOSE) & NASAL DROPS | NASAL SPRAY (METERED DOSE) & NASAL DROPS | NASAL SPRAY (METERED DOSE) & NASAL DROPS |
| 231 | Budesonide Aqueous Nasal Spray BP | Each Spray Delivers: Budesonide BP…………………………………100 mcg Benzalkonium Chloride Solution BP….0.02% v/v (As preservative) in a Buffered Aqueous base...............q.s. | 150 MD Spray | Allergic Rhinitus |
| 232 | Budesonide Aqueous Nasal Spray BP | Each Spray Delivers: Budesonide BP…………………………………64 mcg Benzalkonium Chloride Solution BP..0.02% v/v (As preservative) in a Buffered Aqueous base................q.s. | 120/200 MD Spray | Allergic Rhinitus |
| 233 | Budesonide Aqueous Nasal Spray BP | Each Spray Delivers: Budesonide BP………………………………..50 mcg Benzalkonium Chloride Solution BP…0.02% v/v (As preservative) in a Buffered Aqueous base..............q.s. | 200 MD Spray | Allergic Rhinitus |
| 234 | Ciclesonide Aqueous Nasal Spray | Each Vial Contains: Ciclesonide BP…………………………………50 mcg Composition: Ciclesonide BP…………………………………0.05% w/v Potassium Sorbate BP…………….……….0.12% w/v In Buffered aqueous base………………..q.s. | 120 MD Spray | Allergic Rhinitus |
| 235 | Desmopressin Nasal Spray BP | Each Spray Delivers: Desmopressin Acetate…………………….10 mcg Equivalent to Desmopressin BP……….8.9 mcg Composition: Desmopressin Acetate………………….…0.01% w/v Equivalent to Desmopressin BP…….0.0089%v/v Benzalkonium Chloride Solution BP…0.02 % v/v (As Preservative) Excipient...........................................q.s. | 50 MD Spray | Treat central cranial diabetes insipidus |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 236 | Sodium Chloride Nasal Solution 2.0 % w/v, 15 ml | Composition : Sodium Chloride BP…………………………2.0 % w/v Benzalkonium Chloride Solution BP..0.01% w/v (As preservative) Purified Water BP.............................q.s. | 15 ml Bottle | Decongestant |
| 237 | Fluticasone Furoate Nasal Spray | Each Spray Delivers: Fluticasone Furoate BP…………........27.5 mcg Composition: Fluticasone Furoate BP…………………0.021% w/v Benzalkonium Chloride Solution USP0.01% v/v ( As Preservative) Phenyl Ethyl Alcohol USP………………0.25% v/v ( As Preservative) In a buffered aqueous base.............q.s. | 100/120 MD Spray | Allergic Rhinitus |
| 238 | Fluticasone Nasal Spray BP | Each Spray Delivers: Fluticasone Propionate BP……………50 mcg Composition: Fluticasone Propionate BP…………...0.05% w/v Benzalkonium Chloride Solution BP0.01% v/v ( As Preservative) Phenyl Ethyl Alcohol USP…………..…0.25% v/v ( As Preservative) In a buffered aqueous base............q.s. | 100 MD Spray | Antiasthmatic , Nonallergic |
| 239 | Loteprednol Etabonate Nasal Spray | Each Spray Delivers: Loteprednol Etabonate ……………….0.1 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (as preservative) in a buffered Aqueous base………….q.s. | 100 MD Spray | Antiallergic |
| 240 | Mometasone Aqueous Nasal Spray BP | Each Spray Delivers: Mometasone Furoate BP………………50 mcg Composition: Mometasone Furoate BP………………0.05% w/v Benzalkonium Chloride Solution BP0.02% v/v ( As Preservative) | 120/140 MD Spray | Antiallergic |
| 241 | Mometasone Aqueous Nasal Spray BP | Each Spray Delivers: Mometasone Furoate BP………………50 mcg Composition: Mometasone Furoate BP………………0.05% w/v Benzalkonium Chloride Solution BP0.01% v/v ( As Preservative) Phenyl Ethyl Alcohol USP……………..0.25 % v/v (As Preservative) in a Buffered Aqueous base...............q.s. | 100 MD Spray | Antiallergic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 242 | Olopatadine Nasal Spray | Each Spray delivers: Olopatadone Hyydrochloride USP..665 mcg Equivalent to Olopatadine……………600 mcg Composition: Olopatadone Hydrochloride USP….0.665% w/v Equivalent to Olopatadine……………0.6% w/v Benzalkonium Chloride Solution USP0.02% v/v (as preservative) in a buffered Aqueous base..............q.s. | 120 MD Spray | Antiallergic |
| 243 | Oxymetazoline Hydrochloride Nasal Spray 50 mcg | Each Spray Delivers: Oxymetazoline Hydrochloride USP…50 mcg Composition: Oxymetazoline Hydrochloride USP.0.05 % w/v Benzalkonium Chloride Solution USP0.033% v/v (As Preservative) In aqueous buffered vehicle………….q.s. | 120 MD Spray | Decongestant |
| 244 | Oxymetazoline Hydrochloride and D-Panthenol Nasal Solution | Composition: Oxymetazoline Hydrochloride USP.0.025 % w/v D-Panthenol USP………………………..…5.0 % w/v Benzalkonium Chloride Solution USP0.03% v/v (as preservative) Purified Water USP………………………..q.s. | 10 ml/20ml Bottle | Decongestant |
| 245 | Sodium Chloride Nasal Solution | Composition: Sodium Chloride BP…………………….…0.65% w/v Benzalkonium Chloride Solution BP..0.01% v/v (As preservative) Purified Water…………………………….…q.s. | 15 ml Bottle | Nasal irritation |
| 246 | Sodium Chloride Nasal Solution 0.74 % w/v | Compositiom: Sodium Chloride BP……………………….0.74 % w/v Benzalkonium Chloride Solution BP..0.01 % v/v (as Preservative) Purified Water BP……………………………q.s. | 15 ml Bottle | Nasal irritation |
| 247 | Sodium Chloride Nasal Solution/Spray | Composition: Sodoium Chloride BP…….……………….0.9% w/v Benzalkonium Chloride Solution BP..0.01% v/v (As Preservative) Purified Water BP…………………………….….q.s. | 30 ml Bottle | Nasal irritation |
| 248 | Sodium Chloride Nasal Solution/Spray | Composition: Sodium Chloride BP…….…………………..0.9% w/v Benzalkonium Chloride Solution BP…0.01% v/v (As Preservative) Purified Water BP…………………………….q.s. | 10 ml/15 ml Bottle | Nasal irritation |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 249 | Calcitonin Salmon Nasal Solution USP | Each Spray Delivers: CalcitoninSalmon USP…………………….50 IU (Synthetic Origin) Each ml Contains: Calcitonin Salmon USP……………………550 IU (Synthetic Origin) Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Phenyl Ethyl Alcohol USP..................0.25 % v/v (As Preservative) | 30 MD/60 MD | Postmenopausal osteoporosis |
| 250 | Xylometazoline Hydrochloride Nasal Solution USP 0.1 % w/v | Composition: Xylometazoline Hydrochloride USP.…0.1% w/v Benzalkonium Chloride Solution USP.0.02% v/v (As Preservative) Purified Water USP……….…………………q.s. | 10/15 ml Bottle | Nasal Decongestant |
| 251 | Zolmitriptan Nasal Spray USP | Each Spray Delivers: Zolmitriptan USP…………………………….5 mg Composition: Zolmitriptan USP…………………………….5.0 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) In a buffered Aqueous base..............q.s. | 7 MD Spray | Migraine, Headache |
| 252 | Fluticasone Furoate & Oxymetazoline Hydrochloride Nasal Spray | Each Sparay Delivers: Fluticasone Furoate………………………27.5 mcg Oxymetazoline Hydrochloride USP..50 mcg Composition: Fkuticasone Furoate………………………0.028 % Oxymetazoline Hydrochlorider USP.0.05 % Benzalkonium Chloride Solution USP0.03 % v/v (As Preservative) in a Buffered Aqueous base..............q.s. | 70 MD Spray | Antiasthmatic , Nonallergic |
| 253 | Mometasone Furoate & Azelastine Hydrochloride Nasal Spray | Each Spray Delivers: Mometasone Furoate BP………………50 mcg Azelastine Hydrochloride BP…………140 mcg Composition: Mometasone Furoate BP……………….0.05 % w/v Azelastine Hydrochloride BP………….0.14 % w/v Benzalkonium Chloride BP…………….0.02 % w/w (As p[reservative) in a Buffered Aqueous base.............q.s. | 70/120 MD Spray | Antiallergic |
| 254 | Azelastine Hydrochloride & Fluticasone Propionate Nasal Spray | Each Spray Delivers: Azelastine Hydrochloride BP…………140 mcg Fluticasone Propionate ……………....27.5 mcg Composition: Azelastine Hydrochloride BP……......0.1% w/v Fluticasone Propionate ……….........0.02% w/v Benzalkonium Chloride BP..............0.02% v/v (As Preservative) in a Buffered Aqueous base............q.s. | 70/120 MD Spray | Antiallergic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| EYE\EAR DROPS | EYE\EAR DROPS | EYE\EAR DROPS | EYE\EAR DROPS | EYE\EAR DROPS |
| 255 | Azelastine Hydrochloride Ophthalmic Solution USP | Composition: Azelastine Hydrochloride USP………0.05% w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile aqueous buffered Vehicles…q.s. | 5 ml Bottle | Allergic Rhinitus |
| 256 | Beclometasone aqueous Nasal Spray BP | Each Spray Delivers: Beclometasone Dipropionate BP…100 mcg Composition: Beclomethasone Dipropionate BP..0.1 % w/v Benzalkonium Chloride Solution BP.0.01 % v/v (As preservative) Phenyl Ethyl Alcohol USP…………….0.25 % v/v (As Preservative) In a Buffered Aqueous base)..........q.s. | 120 MD & 200 MD | Antiallergic |
| 257 | Azithromycin & Dexamethasone Eye/Ear Drops | Composition: Azithromycin USP…………………………1.0 % w/v Dexamethasone Sodium Phosphate USP equivalent to Dexamethasone………0.01 % w/v Benzalkonium Chloride solution USP0.02 % v/v (as preservative) Sterile aquous buffered Vehicle……..q.s. | 10 ml Bottle | Allergic Rhinitus |
| 258 | Bepotastine Ophthalmic Solution 1.5 % w/v | Composition: Bepotastine Besilate………………………15.0 mg Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile aqueous Vehicle…………………..q.s. | 5 ml/10 ml Bottle | Treat itching |
| 259 | Betaxolol Ophthalmic Solution USP 0.5 % w/v | Composition: Betaxolol Hydrochloride USP equivalent to Betaxolol ………………….0.5 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile aqueous Vehicle……………………q.s. | 5 ml Bottle | Open Angle Glucoma |
| 260 | Bimatoprost Ophthalmic Solution 0.01% w/v | Composition: Bimatoprost………………………………..0.01 % w/v Benzalkonium Chloride USP………..0.005 % w/v (As Preservative) Sterile Aqueous Vehicle………………q.s. | 3ml Bottle | Glucoma |
| 261 | Bimatoprost Ophthalmic Solution 0.03% w/v | Composition: Bimatoprost……………………………….0.03 % w/v Benzalkonium Chloride USP……….0.005 % w/v (As Preservative) Sterile Aqueous Vehicle………………q.s. | 3ml Bottle | Glucoma |
| 262 | Brimonidine Tartarate & Timolol maleate Ophthalmic Solution | Composition: Brimonidine Tartarate BP…………….0.2 % w/v Timolol maleate BP eqivalent to timolol……………………..0.5 % w/v Benzalkonium Chloride Solution BP0.02 % v/v Sterile aqueous Vehicle…………………q.s. | 10 ml Bottle | Open Angle Glucoma / Ocular Hypertension |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 263 | Brimonidine Tartrate Eye Drops 0.15 % w/v | Composition: Brimonidine Tartrate USP……………0.15% w/v Benzalkonium Chloride Solution USP0.02 % v/v Sterile aqueous Vehicle………………q.s. | 5 ml Bottle | ocular hypertension |
| 264 | Brimonidine Tartrate Eye Drops 0.2% w/v | Composition: Brimonidine Tartrate USP……………0.2 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile Aqueous Vehicle………………q.s. | 5 ml Bottle | ocular hypertension |
| 265 | Brinzolamide & Brimonidine Tartrate Ophthalmic Suspension | Composition: Brinzolamide USP………………………1.0% w/v Brimonidine Tartrate USP………….0.2% w/v Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Sterile aqueous vehicle………………q.s. | 5 ml Bottle | Ocular hypertension |
| 266 | Brimonidine Tartrate Eye Drops 0.15 % w/v | Composition: Brimonidine Tartrate USP…………..0.15% w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile aqueous Vehicle…………….q.s. | 5 ml Bottle | ocular hypertension |
| 267 | Brimonidine Tartrate Eye Drops 0.2% w/v | Composition: Brimonidine Tartrate USP…………0.2 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (As Preservative) Sterile Aqueous Vehicle………………q.s. | 5 ml Bottle | ocular hypertension |
| 268 | Brinzolamide & Brimonidine Tartrate Ophthalmic Suspension | Composition: Brinzolamide USP………………………1.0% w/v Brimonidine Tartrate USP………….0.2% w/v Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Sterile aqueous vehicle………………q.s. | 5 ml Bottle | Ocular hypertension |
| 269 | Carboxymethyl cellulose Sodium Eye Drops BP | Composition: Carboxymethyl cellulose Sodium BP0.5% w/v Stabilized Oxychlorocomplex………………….0.005% w/v Sterile aqueous base……………………q.s. | 10 ml Bottle | Treat dry eyes |
| 270 | Brinzolamide Ophthalmic Suspension USP 1.0 % w/v | Composition: Brinzolamide USP…………………….…1.0 % w/v Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Sterile Aqueous Vehicle………………q.s. | 5 ml Bottle | Ocular hypertension |
| 271 | Carmellose Sodium Eye Drops BP 1.0% w/v | Composition: Carmellose Sodium BP………………1.0 % w/v Stabilized Oxychlorocomplex……………………0.0075% w/v In a buffered aqueous base........q.s. | 10 ml Bottle | Artificial tears |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 272 | Chloramphenicol Ophthalmic Solution USP 0.5% w/v | Composition: Chloramphenicol USP………………0.5% w/v Phenylmercuric Nitrate USP…….0.002% w/v (As Preservative) Sterile aqueous buffered Vehicle.q.s. | 5 ml/10 ml Bottle | Antibacterial |
| 273 | Ciprofloxacin & Dexamethasone Eye Drops 5 ml | Composition: Ciprofloxacin Hydrochloride USP equivalent to Ciprofloxacin…………0.3% w/v Dexamethasone USP………………….0.1%w/v Benzalkonium Chloride Solution USP0.02%v/v (As Preservative) Sterile aqueous buffered vehicle…q.s. | 5/10 ml Bottle | Antibacterial |
| 274 | Ciprofloxacin Ophthalmic solution USP 0.3 % w/v | Composition: Ciprofloxacin Hydrochloride USP equivalent to Ciprofloxacin……….0.3% w/v Benzalkonium Chloride Solution USP0.02%v/v (As Preservative) in a Sterile aqueous buffered vehicle…q.s. | 5/10 ml Bottle | Antibacterial |
| 275 | Dexamethasone Sodium Phosphate Ophthalmic Solution USP 0.1 % w/v | Composition: Dexamethasone Sodium Phosphate USP eq. to Dexamethasone Phosphate..0.1% w/v Benzalkonium Chloride Solution USP.0.02% v/v (As Preservative) Sterile aqueous buffered Vehicle……..q.s. | 5 ml/10 ml Bottle | Steriods |
| 276 | Dorzolamide Hydrochloride Ophthalmic Solution 2 % w/v | Composition: Dorzolamide Hydrochloride USP equivalent to Dorzolamide…………2 % w/v Benzalkonium Chloride Solution USP0.02% v/v (As preservative) Sterile aqueous Vehicle………………q.s. | 5 ml Bottle | Treat Glucoma |
| 277 | Dorzolamide Hydrochloride & Timolol Maleate Ophthalmic Solution USP | Composition: Dorzolamide Hydrochloride USP equivalent to Dorzolamide…………2 % w/v Timolol maleate USP equivalent to Timolol…………………0.5 % w/v Benzalkonium Chloride Solution USP0.02 % v/v (As preservative) Sterile aqueous Vehicle………………q.s. | 5 ml/10 ml Bottle | Treat Glucoma |
| 278 | Fluconazole Eye Drops 0.3 % w/v | Composition: Fluconazole USP……………………….0.3 % w/v Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Aqueous Buffered Vehicle……………q.s. | 5 ml/10 ml Bottle | Antifungal |
| 279 | Gatifloxacin Eye Drops 0.5 % w/v | Composition: Gatifloxacin………………………….……0.5 % w/v Benzalkonium Chloride Solution USP0.02% v/v (As Preservative) Sterile aqueous vehilce………………q.s. | 5 ml Bottle | Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| TOPICAL PREPARATION | TOPICAL PREPARATION | TOPICAL PREPARATION | TOPICAL PREPARATION | TOPICAL PREPARATION |
| 280 | Clotrimazole + Beclomethasone Dipropionate + Neomycin Sulphate + Chlorocresol Cream | 1% + 0.025% + 0.5% + 0.1% | 10g/15g/20g/ 30g/50g | Antifungal + Anti- inflammatory + Antibiotic |
| 281 | Beclomethasone Dipropionate + Clotrimazole + Neomycin Sulphate + Benzyl Alcohol + Chlorocresol Cream | 0.025% + 1% + 0.5% + 1% + 0.1% | 10g/15g/20g/ 30g/50g | Antifungal + Anti- inflammatory + Antibiotic + Preservative |
| 282 | Beclomethasone Dipropionate + Neomycin Sulphate + Miconazole Nitrate Cream | 0.025% + 0.5% + 2% | 10g/15g/20g/ 30g/50g | Antifungal + Anti- inflammatory + Antibiotic |
| 283 | Beclomethasone Dipropionate + Clotrimazole + Neomycin Sulphate Cream | 0.025% + 1% + 0.5% | 10g/15g/20g/ 30g/50g | Antifungal + Anti- inflammatory + Antibiotic |
| 284 | Clobetasol Propionate + Miconazole Nitrate + Neomycin Sulphate Cream | 0.05% + 2% + 0.5% | 10g/15g/20g/ 30g/50g | Antifungal + Anti- inflammatory + Antibiotic |
| 285 | Clobetasol Propionate Cream | 0.05% | 10g/15g/20g/ 30g/50g | Anti-inflammatory (Corticosteroid) |
| 286 | Clobetasol Propionate + Neomycin Sulphate + Clotrimazole Cream | 0.05% + 0.5% + 1% | 10g/15g/20g/ 30g/50g | Anti-inflammatory + Antibiotic + Antifungal |
| 287 | Clobetasol Propionate + Neomycin Sulphate + Miconazole Nitrate + Chlorhexidine Gluconate Cream | 0.05% + 0.5% + 2% + 0.2% | 10g/15g/20g/ 30g/50g | Anti-inflammatory + Antibiotic + Antifungal + Antiseptic |
| 288 | Hydroquinone + Tretinoin + Mometasone Furoate Cream | 2% + 0.025% + 0.1% | 10g/15g/20g/ 30g/50g | Depigmenting + Anti-acne + Anti-inflammatory |
| 289 | Ketoconazole Cream | 2% | 10g/15g/20g/ 30g/50g | Antifungal |
| 290 | Ofloxacin + Clobetasol Propionate + Miconazole Nitrate + Terbinafine HCl + Dexpanthenol Cream | 0.75% + 0.05% + 2% + 1% + 0.05% | 10g/15g/20g/ 30g/50g | Antibacterial + Anti- inflammatory + Antifungal |
| 291 | Tobramycin + Clotrimazole + Clobetasol Propionate Cream | 0.1% + 1% + 0.05% | 10g/15g/20g/ 30g/50g | Antibacterial + Antifungal + Anti-inflammatory |
| 292 | Ofloxacin + Fluocinolone Acetonide + Clotrimazole Cream | 0.5% + 0.01% + 1% | 10g/15g/20g/ 30g/50g | Antibacterial + Anti- inflammatory + Antifungal |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 293 | Luliconazole Cream | 1% | 5g/10g/15g/ 20g/30g/50g | Antifungal |
| 294 | Silver Sulfadiazine Cream | 1% | 5g/10g/15g/ 20g/30g/50g | Antibacterial / Burn care |
| 295 | Fusidic Acid Cream | 2% | 5g/10g/15g/ 20g/30g/50g | Antibacterial |
| 296 | Permethrin Cream | 2.50% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic |
| 297 | Permethrin Cream | 5% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic |
| 298 | Mometasone Furoate + Miconazole Nitrate Cream | 0.1% + 2% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Antifungal |
| 299 | Itraconazole + Ofloxacin + Ornidazole + Clobetasol Propionate Cream | 1% + 0.75% + 2% + 0.05% | 5g/10g/15g/ 20g/30g/50g | Antifungal + Anti- inflammatory + Antibiotic + Antiprotozoal |
| 300 | Terbinafine Hydrochloride + Benzyl Alcohol Cream | 1% + 1% | 5g/10g/15g/ 20g/30g/50g | Antifungal + Preservative |
| 301 | Clotrimazole + Beclomethasone Dipropionate Cream | 1% + 0.025% | 5g/10g/15g/ 20g/30g/50g | Antifungal + Anti- inflammatory |
| 302 | Silver Nitrate + Chlorhexidine Gluconate Cream | 0.2% + 0.2% | 5g/10g/15g/ 20g/30g/50g | Antiseptic + Antibacterial |
| 303 | Clobetasol Propionate + Gentamycin + Tolnaftate + Iodochlorhydroxyquinoline + Clotrimazole Cream | 0.05% + 0.1% + 1% + 1% + 1% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Antibiotic + Antifungal + Antiseptic |
| 304 | Clotrimazole Cream | 1% | 5g/10g/15g/ 20g/30g/50g | Antifungal |
| 305 | Aciclovir Cream | 5% | 5g/10g/15g/ 20g/30g/50g | Antiviral |
| 306 | Hydroquinone Cream | 2% | 5g/10g/15g/ 20g/30g/50g | Depigmenting |
| 307 | Itraconazole + Terbinafine HCl Cream | 1% + 1% | 5g/10g/15g/ 20g/30g/50g | Antifungal + Antibacterial |
| 308 | Tretinoin Cream | 0.03% | 5g/10g/15g/ 20g/30g/50g | Anti-acne / Keratolytic |
| 309 | Tretinoin Cream | 0.05% | 5g/10g/15g/ 20g/30g/50g | Anti-acne / Keratolytic |
| 310 | Clindamycin Phosphate + Nicotinamide Gel | 1% + 4% | 5g/10g/15g/ 20g/30g/50g | Anti-acne / Antibacterial |
| 311 | Clindamycin Phosphate + Adapalene Gel | 1% + 0.1% | 5g/10g/15g/ 20g/30g/50g | Anti-acne / Antibacterial |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 312 | Gammabenzene Hexachloride + Cetrimide Lotion | 1% + 0.1% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic + Antiseptic |
| 313 | Gammabenzene Hexachloride Lotion | 1% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic |
| 314 | Gammabenzene Hexachloride + Cetrimide Lotion | 0.1% + 0.1% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic + Antiseptic |
| 315 | Permethrin Lotion | 1% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic |
| 316 | Betamethasone Dipropionate + Salicylic Acid Lotion | 0.05% + 2% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Keratolytic |
| 317 | Permethrin Lotion | 5% | 5g/10g/15g/ 20g/30g/50g | Anti-parasitic |
| 318 | Salicylic Acid + Benzoic Acid Lotion | 7.31% + 2.44% | 5g/10g/15g/ 20g/30g/50g | Keratolytic + Antiseptic |
| 319 | Beclomethasone Dipropionate + Salicylic Acid Ointment | 0.025% + 3% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Keratolytic |
| 320 | Clobetasol Propionate + Salicylic Acid Ointment | 0.05% + 6% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Keratolytic |
| 321 | Ornidazole + Povidone Iodine Ointment | 1% + 5% | 5g/10g/15g/ 20g/30g/50g | Antiprotozoal + Antiseptic |
| 322 | Povidone Iodine Ointment | 5% | 5g/10g/15g/ 20g/30g/50g | Antiseptic |
| 323 | Povidone Iodine Ointment | 10% | 5g/10g/15g/ 20g/30g/50g | Antiseptic |
| 324 | Sucralfate + Tinidazole + Povidone Iodine Ointment | 7% + 1% + 5% | 5g/10g/15g/ 20g/30g/50g | Antiulcer + Antiprotozoal + Antiseptic |
| 325 | Sucralfate + Ornidazole + Povidone Iodine Ointment | 7% + 1% + 5% | 5g/10g/15g/ 20g/30g/50g | Antiulcer + Antiprotozoal + Antiseptic |
| 326 | Mupirocin Ointment | 2% | 5g/10g/15g/ 20g/30g/50g | Antibacterial |
| 327 | Benzoic Acid + Salicylic Acid Ointment | 6% + 3% | 5g/10g/15g/ 20g/30g/50g | Keratolytic + Antiseptic |
| 328 | Povidone Iodine + Metronidazole + Aloe Vera Ointment | 5% + 1% + 1.5% | 5g/10g/15g/ 20g/30g/50g | Antiseptic + Antiprotozoal + Soothing |
| 329 | Clobetasol Propionate + Salicylic Acid + Aloe Vera Ointment | 0.05% + 3% + 2% | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Keratolytic + Soothing |
| 330 | Neomycin Sulphate + Bacitracin Ointment | 3300 IU + 250 IU | 5g/10g/15g/ 20g/30g/50g | Antibiotic |
| 331 | Neomycin Sulphate + Polymyxin B + Bacitracin Ointment | 3400 IU + 5000 IU + 400 IU | 5g/10g/15g/ 20g/30g/50g | Antibiotic |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 332 | Betamethasone Dipropionate + Clotrimazole + Gentamicin Sulfate Ointment | 0.5 mg + 10 mg + 1 mg | 5g/10g/15g/ 20g/30g/50g | Anti-inflammatory + Antifungal + Antibiotic |
| Cardiovascular System | Cardiovascular System | Cardiovascular System | Cardiovascular System | Cardiovascular System |
| 333 | Heparin Sodium + Benzyl Nicotinate Ointment | 50 IU + 2 mg | 5g/10g/15g/ 20g/30g/50g | Anticoagulant / Vasodilator |
| Dental | Dental | Dental | Dental | Dental |
| 334 | Potassium Nitrate + Sodium Monofluoro- phosphate Gel | 5% + 0.7% | 5g/10g/15g/ 20g/30g/50g | Desensitizing Agent |
| 335 | Potassium Nitrate + Triclosan +Sodium Monofluorophosphate Gel | 5% + 0.3% + 0.7% | 5g/10g/15g/ 20g/30g/50g | Desensitizing Agent + Antibacterial |
| 336 | Chlorhexidine Gluconate Mouth Wash | 0.20% | 5g/10g/15g/ 20g/30g/50g | Antiseptic |
| Genitourinary | Genitourinary | Genitourinary | Genitourinary | Genitourinary |
| 337 | Miconazole Nitrate Cream | 2% | 5g/10g/15g/ 20g/30g/50g | Antifungal (Vaginal) |
| 338 | Clotrimazole Cream | 1% | 5g/10g/15g/ 20g/30g/50g | Antifungal (Vaginal) |
| Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal | Musculoskeletal |
| 339 | Diclofenac Diethylamine + Linseed Oil + Methyl Salicylate + Menthol Gel | 1.16% + 3% + 10% + 5% | 5g/10g/15g/ 20g/30g/50g | NSAID + Analgesic |
| 340 | Diclofenac Diethylamine + Linseed Oil + Methyl Salicylate + Menthol Gel | 1.16% + 3% + 10% + 0.5% | 5g/10g/15g/ 20g/30g/50g | NSAID + Analgesic |
| 341 | Piroxicam + Linseed Oil + Methyl Salicylate + Menthol + Capsaicin Gel | 0.5% + 3% + 10% + 5% + 0.01% | 5g/10g/15g/ 20g/30g/50g | NSAID + Analgesic + Counterirritant |
| 342 | Diclofenac Diethylamine + Linseed Oil + Methyl Salicylate + Menthol + Capsaicin Gel | 1.16% + 3% + 10% + 0.5% + 0.01% | 5g/10g/15g/ 20g/30g/50g | NSAID + Analgesic + Counterirritant |
| 343 | Diclofenac Diethylamine eq. to Diclofenac Sodium Gel | 1.16% (eq. 1%) | 5g/10g/15g/ 20g/30g/50g | NSAID |
| 344 | Diclofenac Diethylamine + Virgin Linseed Oil + Methyl Salicylate + Menthol Gel | 1.16% + 3% + 10% + 5% | 5g/10g/15g/ 20g/30g/50g | NSAID + Analgesic + Counterirritant |
| 345 | Methyl Nicotinate + Mephenesin + Methyl Salicylate + Menthol Ointment | 1% + 2.5% + 8% + 2% | 5g/10g/15g/ 20g/30g/50g | Vasodilator + Muscle Relaxant + Counterirritant |
| 346 | Heparin Sodium + Benzyl Nicotinate Ointment | 50 IU + 2 mg | 5g/10g/15g/ 20g/30g/50g | Anticoagulant / Vasodilator |
| Sr. No. | Generic Name | Composition | Packing | Category |
| 347 | Etodolac Extended Release Tablets USP 400 mg | Each film coated extended release tablet contains: Etodolac IP 400 mg Colour: Approved Colour(s) | ||
| 348 | Diacerein and Aceclofenac Tablets | Each film coated tablet contains: Diacerein IP 50 mg Aceclofenac IP 100 mg Colours : Approved colours | ||
| 349 | Diacerein and Glucosamine Sulphate Tablets | Each film coated tablet contains: Diacerein IP 50 mg Glucosamine Sulphate 500 mg Colours : Approved colours | ||
| 350 | Metformin Hydrochloride Prolonged- release Tablets IP 1000 mg | Each uncoated Prolonged- release tablet contains: Metformin Hydrochloride IP 1000 mg | ||
| 351 | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: Lornoxicam IP 4 mg Paracetamol IP 325 mg Colours : Approved colours | ||
| 352 | Lornoxicam and Paracetamol Tablets | Each film coated tablet contains: Lornoxicam IP 8 mg Paracetamol IP 325 mg Colours : Approved colours | ||
| 353 | Ciprofloxacin and Ornidazole Tablets | Each film coated tablet contains: Ciprofloxacin hydrochloride IP Equivalent to Ciprofloxacin 500 mg Ornidazole IP 500 mg Colours : Approved colours | ||
| 354 | Acetaminophen and Tramadol Hydrochloride Tablets IP | Each film coated tablet contains: Acetaminophen IP 325 mg Tramadol Hydrochloride USP 37.5 mg Colour: Approved colours(s) | ||
| 355 | Montelukast Sodium and Levocetirizine Dispersible Tablets | Each uncoated dispersible tablet contains: Montelukast Sodium IP Equivalent to Montelukast 5 mg Levocetirizine Dihydrochloride IP 2.5 mg | ||
| 356 | Clopidogrel Tablets IP 75 mg | Each film coated tablet contains : Clopidogrel Bisulphate IP eq. Clopidogrel 75 mg Colour: Approved Colours | ||
| 357 | Aceclofenac and Paracetamol Tablets IP | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Colours : Approved colours | ||
| Sr. No. | Generic Name | Composition | Packing | Category |
| 358 | Aceclofenac, Paracetamol and Serratiopeptidase Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Serratiopeptidase IP 10 mg (enteric coated granules eq. to enzyme activity 20,000 units) Colours : Approved colours | ||
| 359 | Rabeprazole Sodium Gastro – Resistant Tablets IP 20 mg | Each Enteric Coated Tablet Contains: Rabeprazole Sodium IP 20 mg Colours : Approved colours | ||
| 360 | Ofloxacin and Ornidazole Tablets IP | Each Film Coated Tablet Contains : Ofloxacin IP 200 mg Ornidazole IP 500 mg Colours : Approved colours | ||
| 361 | Nimesulide mouth dissolving tablets 100 mg | Each uncoated dispersible tablet contains: Nimesulide BP 100 mg Colour Approved colours. | ||
| 362 | Levofloxacin Hemihydrate and Ornidazole Tablets | Each film coated tablet contains: Levofloxacin Hemihydrate IP eq. to Levofloxacin 250 mg Ornidazole IP 500 mg Colour: Approved colours. | ||
| 363 | Betahistine Tablets IP 8 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 8 mg Excipients q. s. | ||
| 364 | Betahistine Tablets IP 16 mg | Each uncoated tablet contains: Betahistine Hydrochloride IP 16 mg Excipients q. s. | ||
| 365 | Metoprolol Succinate Extended release Tablets IP | Each film coated extended release tablet contains: Metoprolol Succinate IP 23.75 mg Equivalent to Metoprolol Tartrate 25 mg Colours: Approved colour(s) | ||
| 366 | Aceclofenac , Paracetamol and Chlorzoxazone Tablets | Each film coated tablet contains: Aceclofenac IP 100 mg Paracetamol IP 325 mg Chlorzoxazone USP 250 mg Colours : Approved colours | ||
| 367 | Diclofenac Sodium and Paracetamol Tablets IP | Each uncoated tablet contains: Diclofenac Sodium IP 50 mg Paracetamol IP 325 mg | ||
| 368 | Paracetamol Tablets IP | Each uncoated tablet contains: Paracetamol IP 500 mg | ||
| 369 | Nimesulide Tablets | Each uncoated tablet contains: Nimesulide BP 100 mg | ||
| Sr. No. | Generic Name | Composition | Packing | Category |
| 370 | Atorvastatin Calcium Tablets IP 10 mg | Each film coated tablet contains: Atorvastatin Calcium IP Equivalent to Atorvastatin 10 mg Colours : Approved colours | ||
| 371 | Pantoprazole Gastro – Resistant Tablets IP 40 mg | Each enteric coated tablet contains: Pantoprazole Sodium Sesquihydrate IP eq. to Pantoprazole 40 mg Excipients q.s. Colours : Approved colours | ||
| 372 | Telmisartan Tablets IP 80 mg | Each uncoated tablet contains: Telmisartan IP 80 mg Colours : Approved colours | ||
| 373 | Montelukast Sodium Chewable Tablets 4 mg | Each uncoated chewable tablet contains: Montelukast Sodium IP Equivalent to Montelukast 4 mg Excipients q. s. | ||
| 374 | Azithromycin Tablets IP 500 mg | Each film coated tablet contains: Azithromycin dihydrate IP Equivalent to Azithromycin 500 mg Excipients q.s. Colours : Approved colours | ||
| 375 | Pregabalin Capsule IP 300 mg | Each hard gelatin capsule contains: Pregabalin IP 300 mg Approved colours used in empty hard gelatin capsule shells | ||
| 376 | Enteric Coated Rabeprazole Sodium and Levosupiride Sustained Release Capsules | Each hard gelatin capsule contains: Rabeprazole Sodium IP 20 mg (As enteric coated pellets) Levosupiride 75 mg (As Sustained release pellets) Approved colours used in hard gelatin capsule shells | ||
| 377 | Rabeprazole Enteric Coated and Domperidone SR Capsule | Each hard gelatin capsules contains : Rabeprazole Sodium IP 20 mg (As enteric coated pellets) Domperidone IP 30 mg (As Sustained Release pellets ) Approved colours used in empty hard gelatin capsule shells. | ||
| 378 | Tramadol Hydrochloride Capsules BP | Each hard gelatin capsule contains: Tramadol Hydrochloride BP 100 mg Excipients q.s. Approved colours used in empty hard gelatin capsule shells | ||
| Sr. No. | Generic Name | Composition | Packing | Category |
| 379 | Omeprazole Capsule IP 20 mg | Each hard gelatin capsule contains: Omeprazole IP 20 mg (As enteric coated pellets) Excipients q.s. Approved colours used in empty hard gelatin capsule shells. | ||
| 380 | Omeprazole and Domperidone Capsules IP | Each hard gelatin capsule contains: Omeprazole IP 20 mg (As enteric coated pellets) Domperidone IP 10 mg (As coated pellets) Approved colours used in hard gelatin capsule shells |